title: Acute encephalopathy with vigabatrin.
authors.forename: A
authors.initials: A
authors.lastname: Sälke-Kellermann
authors.forename: H
authors.initials: H
authors.lastname: Baier
authors.forename: B
authors.initials: B
authors.lastname: Rambeck
authors.forename: H E
authors.initials: HE
authors.lastname: Boenigk
authors.forename: P
authors.initials: P
authors.lastname: Wolf
mesh_terms: D000612:4-Aminobutyrate Transaminase / Q000009:adverse effects* / Q000037:antagonists & inhibitors*; D000293:Adolescent; D000328:Adult; D000614:Aminocaproates / Q000009:adverse effects*; D000927:Anticonvulsants / Q000009:adverse effects*; D002220:Carbamazepine / Q000009:adverse effects; D003128:Coma / Q000139:chemically induced*; D004569:Electroencephalography / Q000187:drug effects; D004828:Epilepsies, Partial / Q000188:drug therapy; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D005260:Female; D006801:Humans; D012640:Seizures / Q000139:chemically induced*; D020888:Vigabatrin
chemical_list: D000614:Aminocaproates; D000927:Anticonvulsants; D002220:Carbamazepine; D000612:4-Aminobutyrate Transaminase; D020888:Vigabatrin